Lachance P - Search Results

1

Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease.

Lindner HA, Lytvyn V, Qi H, Lachance P, Ziomek E, Ménard R. Lindner HA, et al. Among authors: lachance p. Arch Biochem Biophys. 2007 Oct 1;466(1):8-14. doi: 10.1016/j.abb.2007.07.006. Epub 2007 Jul 14. Arch Biochem Biophys. 2007. PMID: 17692280 Free PMC article.

2

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.

Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Ménard R. Lindner HA, et al. Among authors: lachance p. J Virol. 2005 Dec;79(24):15199-208. doi: 10.1128/JVI.79.24.15199-15208.2005. J Virol. 2005. PMID: 16306591 Free PMC article.

3

Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.

Therrien C, Lachance P, Sulea T, Purisima EO, Qi H, Ziomek E, Alvarez-Hernandez A, Roush WR, Ménard R. Therrien C, et al. Among authors: lachance p. Biochemistry. 2001 Mar 6;40(9):2702-11. doi: 10.1021/bi002460a. Biochemistry. 2001. PMID: 11258881

4

Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides.

Chowdhury SF, Sivaraman J, Wang J, Devanathan G, Lachance P, Qi H, Ménard R, Lefebvre J, Konishi Y, Cygler M, Sulea T, Purisima EO. Chowdhury SF, et al. Among authors: lachance p. J Med Chem. 2002 Nov 21;45(24):5321-9. doi: 10.1021/jm020238t. J Med Chem. 2002. PMID: 12431059

5

Contribution of active site residues to substrate hydrolysis by USP2: insights into catalysis by ubiquitin specific proteases.

Zhang W, Sulea T, Tao L, Cui Q, Purisima EO, Vongsamphanh R, Lachance P, Lytvyn V, Qi H, Li Y, Ménard R. Zhang W, et al. Among authors: lachance p. Biochemistry. 2011 May 31;50(21):4775-85. doi: 10.1021/bi101958h. Epub 2011 May 4. Biochemistry. 2011. PMID: 21542621

6

Substrate specificity of the streptococcal cysteine protease.

Nomizu M, Pietrzynski G, Kato T, Lachance P, Menard R, Ziomek E. Nomizu M, et al. Among authors: lachance p. J Biol Chem. 2001 Nov 30;276(48):44551-6. doi: 10.1074/jbc.M106306200. Epub 2001 Sep 11. J Biol Chem. 2001. PMID: 11553627 Free article.

7

Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.

Ménard R, Therrien C, Lachance P, Sulea T, Qo H, Alvarez-Hernandez AD, Roush WR. Ménard R, et al. Among authors: lachance p. Biol Chem. 2001 May;382(5):839-45. doi: 10.1515/BC.2001.102. Biol Chem. 2001. PMID: 11517939

8

E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions.

Gour-Salin BJ, Lachance P, Magny MC, Plouffe C, Ménard R, Storer AC. Gour-Salin BJ, et al. Among authors: lachance p. Biochem J. 1994 Apr 15;299 ( Pt 2)(Pt 2):389-92. doi: 10.1042/bj2990389. Biochem J. 1994. PMID: 8172599 Free PMC article.

9

Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B.

Gour-Salin BJ, Lachance P, Plouffe C, Storer AC, Ménard R. Gour-Salin BJ, et al. Among authors: lachance p. J Med Chem. 1993 Mar 19;36(6):720-5. doi: 10.1021/jm00058a008. J Med Chem. 1993. PMID: 8459399

10

Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factor.

Ménard R, Schoenhofen IC, Tao L, Aubry A, Bouchard P, Reid CW, Lachance P, Twine SM, Fulton KM, Cui Q, Hogues H, Purisima EO, Sulea T, Logan SM. Ménard R, et al. Among authors: lachance p. Antimicrob Agents Chemother. 2014 Dec;58(12):7430-40. doi: 10.1128/AAC.03858-14. Epub 2014 Sep 29. Antimicrob Agents Chemother. 2014. PMID: 25267679 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page